Free tools Windows power users keep installed
One-click scans. No signup required.
Short answer: Retro Biosciences was reported on January 24, 2025, to be seeking up to $1 billion for therapies intended to add 10 healthy years to human life. That was a fundraising target, not proof that the company had extended anyone’s lifespan. On May 22, 2026, Retro announced an initial financing close at a $1.8 billion pre-money valuation, but did not disclose how much cash it had raised or confirm that the full $1 billion target was closed.
What the January 2025 announcement actually said
TechCrunch, Endpoints and Fortune reported that Retro Biosciences was pursuing a financing round of up to $1 billion. The proposed capital was intended to advance several drug programs toward human testing, alongside work in cell therapy, tissue reprogramming and protein engineering. The company’s stated ambition is to add 10 healthy years to human lifespan, a mission rather than a clinically demonstrated result.
The wording matters: “raising $1 billion” described an in-progress financing effort. It did not establish that investors had already transferred $1 billion to Retro. Contemporary coverage included TechCrunch’s report, an Endpoints account and Fortune’s coverage.
The latest financing status
Retro’s May 22, 2026 announcement says it reached the initial close of a new financing round at a $1.8 billion pre-money valuation, led by 4P Capital and other investors. A pre-money valuation is the company’s agreed value before new investment is added; it is not the amount of money raised.
The Tool Desk
Outbyte Driver Updater FREEScan for outdated or missing drivers - takes under a minuteDriver Scan →Outbyte PC Repair FREERepair Windows errors before they cause bigger problemsFix Now →#1 Best Overall
- The Ultimate Wellness & Beauty Set: Introducing the Parrox Forever Young Set, your all-in-one bundle for supporting vitality and radiance. This set synergistically combines a wellness formula featuring NAD+ precursors with a beauty complex containing Collagen Peptides. Experience comprehensive support for your wellness goals in one simple, curated collection designed for your modern lifestyle.
- Support Your Daily Vitality: This advanced formula supports your body's natural processes with a powerful combination of NAD+ precursors, including Liposomal NAD and Nicotinamide Riboside. This blend is enhanced with the polyphenol Resveratrol and Lion's Mane mushroom extract to promote a sense of daily clarity, focus, and overall well-being.
- Nourish Your Natural Beauty: Nourish your natural glow with a comprehensive matrix of Collagen Peptides Types I, II, III, V, and X. This robust formula is fortified with beauty powerhouses Biotin & Keratin to support strong hair and resilient nails, while Hyaluronic Acid works to deeply hydrate the skin, promoting a smooth, vibrant, and youthful appearance from within.
- Essential Nutrient Blend: This premium set is fortified with key nutrients for complete, foundational support. Zinc is an essential mineral that plays a vital role in overall wellness. The powerful flavonoid Quercetin complements the formula's ingredients, while Magnesium is included to offer broad support for hundreds of important bodily functions.
- A Curated Set of Unmatched Quality: Get the best of both worlds in one convenient package. Both supplements in the Forever Young Set are proudly made in the USA in a GMP-certified facility, using high-purity ingredients. This clean, filler-free combination offers a trusted, streamlined approach to achieving your daily wellness goals.
Because Retro did not publish the dollar amount in that initial close, the announcement does not prove that the company raised $1 billion. “Initial close” can indicate that a financing has additional closings, but Retro’s statement does not specify the final size or completion date. The company’s update is available at Retro’s financing announcement.
| Date | What was reported |
|---|---|
| 2022 | Reporting described $180 million in personal backing from Sam Altman as Retro emerged from stealth. |
| January 24, 2025 | News outlets reported that Retro was seeking a $1 billion financing round. |
| 2025 | Retro says its lead candidate, RTR242, entered the clinic. |
| May 22, 2026 | Retro announced an initial close at a $1.8 billion pre-money valuation. |
| As of the latest cited materials | No disclosed figure confirms that the entire $1 billion target was raised. |
Sam Altman’s role—and what it does not mean
MIT Technology Review reported that Altman personally invested $180 million in Retro’s earlier financing. That figure refers to the company’s previous funding, not automatically to the 2025 target. “Backed by Sam Altman” therefore means personal financial backing, not that OpenAI owns Retro or supplied the reported $1 billion.
OpenAI and Retro have also collaborated on research. That relationship is separate from Altman’s personal investment, and Retro remains an independent biotechnology company. The earlier investment was described by MIT Technology Review.
Rank #2
- The Longevity Bundle is the perfect bundle for people wanting a nutrient focus that helps them maintain the health they have now while supporting any new levels they want to achieve
- ReMag, Dr. Dean's Pico-Ionic Magnesium activates 300 body enzyme systems and is fully absorbed at the cellular level. Responsible for 80% of known metabolic functions
- Vitamin C ReSet» is a vitamin C powder that provides your body essential antioxidant power in a berrylicious flavor that's easy to drink. Contains the most popular and highly absorbed form of vitamin C, ascorbic acid
- D3K2 ReSet contains 3,600IU of vitamin D3, 100mcg of Vitamin K2, and 11mg of RnA Powder
- ReAline Vitamin B complex supplement includes all eight B Vitamins, as well as L-Methionine and Taurine
What Retro is developing
Retro describes a portfolio rather than a single “anti-aging pill.” Its public pipeline covers conventional drug development and biological-engineering approaches aimed at age-related disease. These include:
- small-molecule and other drug programs;
- cell-therapy research and manufacturing;
- tissue reprogramming;
- AI-enabled protein engineering; and
- interventions aimed at cellular mechanisms associated with aging.
Its pipeline page and company materials present these as development programs. A mission to increase healthy lifespan does not necessarily become a regulatory indication called “aging”; medicines generally enter trials for specific diseases, symptoms or measurable biological conditions.
Where RTR242 stands
Retro’s 2026 update identifies RTR242 as its lead clinical candidate. The company says the program moved from indication selection to first-in-human dosing in 15 months, entered the clinic in 2025 and was in Phase 1 by May 2026. It also described additional first-in-human milestones planned for 2026 and 2027.
Rank #3
- Inside Support: Each serving delivers 20 grams of Bio-Peptides Superior Absorption Collagen to support healthy hair, skin, nails, and joints from the inside*^
- Outside Support: Serum helps support clearer, calmer, hydrated, and healthy-looking skin
- Effortless Routine: One scoop + one serum = one easy daily ritual
- Simple Formulas: No unnecessary additives; designed for real-life routines.
Third-party descriptions characterize RTR242 as a small molecule intended to restore lysosomal function, part of the cell’s recycling and autophagy system. That mechanism is reported, not proof of clinical benefit; the available public material does not establish that RTR242 extends life or treats a disease effectively.
Phase 1 is primarily an initial evaluation of safety, tolerability, dosing and sometimes biological signals. Even a successful Phase 1 study would not demonstrate longer human lifespan. Later controlled trials would need to show benefits for a defined disease or health outcome, with long-term evidence required for any lifespan claim.
How artificial intelligence fits in
OpenAI and Retro reportedly worked on GPT-4b micro, a model specialized for protein engineering and longevity research, as described by MIT Technology Review. A system like this may help generate protein designs, rank candidates or suggest biological hypotheses.
Rank #4
- SUGAR-FREE BEAUTY HYDRATION DRINK: A bright, citrusy sip that makes your beauty and hydration routine something you actually look forward to. Sugar-free, gluten-free, keto-friendly, paleo-friendly, and made without artificial colors or flavors. Choose from Lemon Ice, Lemon Iced Tea, or Strawberry Lemonade.
- CLINICALLY STUDIED VERISOL COLLAGEN PEPTIDES: Every serving brings 5g of high-quality hydrolyzed collagen featuring VERISOL — bioactive collagen peptides studied for their role in supporting skin elasticity, firmness, and a smoother, more youthful look. Beauty really does start from within.
- DERMAVAL ANTIOXIDANT SKIN DEFENSE: A polyphenol-rich botanical blend of pomegranate, acerola, camu-camu, asparagus, and mangosteen — antioxidants that help your skin stand up to everyday stressors, so it stays looking healthy, radiant, and like you on your best day.
- HYALURONIC ACID FOR DEEP HYDRATION: Hyaluronic acid is nature's moisture magnet — it holds many times its weight in water. Paired with magnesium and potassium electrolytes, every sip helps your skin drink deep for that plump, dewy, well-hydrated glow you can feel.
- EASY-TO-MIX COLLAGEN HYDRATION DRINK YOU'LL ACTUALLY ENJOY: Just stir 2 scoops into 6–8 oz of cold water and you're set. No clumping, no chalky aftertaste — just a delicious daily ritual your skin, hydration, and energy will thank you for.
AI does not remove the need for laboratory experiments, toxicology, manufacturing controls or clinical trials. A model’s ability to propose a protein is not evidence that a resulting therapy works in people, and GPT-4b micro is not a consumer longevity treatment or a feature of ChatGPT.
Independent reader supportYour contribution helps us test, update, and keep practical guides available for everyone.Why the “10 healthy years” goal is difficult to prove
Healthspan is not the same as lifespan
Retro’s wording focuses on healthy years—healthspan—rather than simply postponing death. A treatment could improve a particular age-related disease without extending total lifespan, or extend survival while leaving quality of life unchanged.
Aging has many biological causes
Aging involves interacting changes across cells, tissues and organs. A portfolio can spread risk across mechanisms, but it also means no single early result validates the company’s overall mission.
Best Value
- The Highly Purified Form of Ca AKG - Toniiq Ca AKG brings some of the most purified Calcium Alpha-Ketoglutarate on the market. Our AKG supplement contains a third-party tested minimum 1500mg formula. Higher purity and a higher dosage means more of the active compounds in each serving that give Ca AKG its powerful properties.
- Highly Purified and Bioavailable - Calcium AKG has amazing health benefits, but purity and absorption have always been a major challenge; something most other Calcium AKG supplements don’t provide as it requires an extra step (and expense) in the manufacturing process. At a 99%+ purity level, Toniiq Ca AKG provides some of the purest, most potent Calcium Alpha-Ketoglutarate available.
- Setting a New Standard for Purity - To ensure that you are getting the highest-quality supplements, each batch is tested for quality and purity both during and after manufacturing.
- Quality, First, and Foremost - Toniiq products are produced in a GMP-certified, state-of-the-art manufacturing facility right here in the USA.
- Each Batch is Individually Tested - We test each batch of our supplements both ourselves and through a third-party independent laboratory to ensure our ingredients contain the correct standardized level of purity and active ingredients. We also test each batch for any possible additives, contaminants, and impurities to ensure the highest level of quality.
Clinical endpoints take time
Regulators generally evaluate medicines against defined diseases or measurable conditions. Lifespan is a long-term endpoint, so practical development is more likely to begin with safety, biomarkers and disease-specific outcomes than with a trial designed to prove an extra decade of life.
Early safety can outweigh ambitious claims
Cellular reprogramming, genetic manipulation and other rejuvenation strategies require particular attention to unintended biological effects. Until controlled human data are disclosed, claims about reversing aging or making people live longer remain unverified.
How to evaluate Retro’s progress
- Separate target from close. A reported $1 billion target is not the same as cash raised; the 2026 $1.8 billion figure is a valuation.
- Check the development stage. RTR242 being in Phase 1 means early human testing, not demonstrated efficacy.
- Look for the indication. Ask which disease or measurable condition each candidate is intended to treat.
- Prioritize independent evidence. Trial registrations, peer-reviewed results, regulatory filings and disclosed clinical data are more informative about efficacy than company financing announcements.
- Read AI claims narrowly. Discovery assistance can accelerate candidate selection but cannot substitute for validation in cells, animals and people.
Retro in the longevity-investing landscape
Retro is part of a broader group of heavily funded longevity companies, including Altos Labs and Unity Biotechnology, pursuing cellular reprogramming, regenerative medicine, senolytics and other approaches. Large capital reserves can support multiple expensive programs and manufacturing work, but portfolio breadth can make it harder to determine which mechanism will succeed.
For investors, the central question is not whether billionaires can finance longevity research. It is whether a specific candidate can produce a reproducible, clinically meaningful result for a defined disease or health outcome. A company can be scientifically ambitious and financially well supported while remaining years—or decades—from proving a lifespan benefit.
Quick wins for a faster PC:
Repair Windows errors before they cause bigger problemsFix Now →Scan for outdated or missing drivers - takes under a minuteDriver Scan →Clear out junk files and repair common Windows errorsFree Scan →Bottom line
Retro Biosciences is a clinically active longevity biotechnology company, not a company that has already extended human life. The January 2025 story concerned a proposed $1 billion raise. The latest cited update, from May 22, 2026, reports an initial close at a $1.8 billion pre-money valuation without disclosing the amount raised. Retro’s mission is to add 10 healthy years, but its publicly described evidence remains at the level of early clinical development and research programs.
Quick Recap
Product prices and availability are accurate as of the date/time indicated and are subject to change. Any price and availability information displayed on Amazon at the time of purchase will apply.
